OM

Opaleye Management Portfolio holdings

AUM $758M
1-Year Est. Return 77.57%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+77.57%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$418M
AUM Growth
+$84.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
52
New
Increased
Reduced
Closed

Top Buys

1
+$85.1M
2
+$6.69M
3
+$5.28M
4
KROS icon
Keros Therapeutics
KROS
+$5.03M
5
NTLA icon
Intellia Therapeutics
NTLA
+$4.87M

Top Sells

1
+$5.52M
2
+$5.04M
3
+$4.21M
4
PHAT icon
Phathom Pharmaceuticals
PHAT
+$3.54M
5
KPTI icon
Karyopharm Therapeutics
KPTI
+$2.95M

Sector Composition

1 Healthcare 98.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
– –
-496,000
52
– –
-125,500
1 2
3